These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8794883)

  • 21. Mapping the binding site of six nonpeptide antagonists to the human V2-renal vasopressin receptor.
    Macion-Dazard R; Callahan N; Xu Z; Wu N; Thibonnier M; Shoham M
    J Pharmacol Exp Ther; 2006 Feb; 316(2):564-71. PubMed ID: 16234409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single amino acid substitutions and deletions that alter the G protein coupling properties of the V2 vasopressin receptor identified in yeast by receptor random mutagenesis.
    Erlenbach I; Kostenis E; Schmidt C; Serradeil-Le Gal C; Raufaste D; Dumont ME; Pausch MH; Wess J
    J Biol Chem; 2001 Aug; 276(31):29382-92. PubMed ID: 11375990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Charged residues of the conserved DRY triplet of the vasopressin V1a receptor provide molecular determinants for cell surface delivery and internalization.
    Hawtin SR
    Mol Pharmacol; 2005 Oct; 68(4):1172-82. PubMed ID: 16049168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8.
    Pena A; Murat B; Trueba M; Ventura MA; Wo NC; Szeto HH; Cheng LL; Stoev S; Guillon G; Manning M
    J Med Chem; 2007 Feb; 50(4):835-47. PubMed ID: 17300166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.
    Serradeil-Le Gal C; Lacour C; Valette G; Garcia G; Foulon L; Galindo G; Bankir L; Pouzet B; Guillon G; Barberis C; Chicot D; Jard S; Vilain P; Garcia C; Marty E; Raufaste D; Brossard G; Nisato D; Maffrand JP; Le Fur G
    J Clin Invest; 1996 Dec; 98(12):2729-38. PubMed ID: 8981918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular aspects of vasopressin receptor function.
    Schöneberg T; Kostenis E; Liu J; Gudermann T; Wess J
    Adv Exp Med Biol; 1998; 449():347-58. PubMed ID: 10026824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of N-glycosylation on ligand binding affinity of rat V1a vasopressin receptor.
    Lee KH; Ahn JI; Yu DH; Jeong HS; Lee SH; Kim KS; Chung IY; Kim JH; Lee YS
    Biochem Biophys Res Commun; 2001 Aug; 286(4):707-13. PubMed ID: 11520055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones.
    Cheong HI; Cho HY; Park HW; Ha IS; Choi Y
    Nephrology (Carlton); 2007 Apr; 12(2):113-7. PubMed ID: 17371330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycosylation of the receptor guanylate cyclase C: role in ligand binding and catalytic activity.
    Ghanekar Y; Chandrashaker A; Tatu U; Visweswariah SS
    Biochem J; 2004 May; 379(Pt 3):653-63. PubMed ID: 14748740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential coupling of the vasopressin V1b receptor through compartmentalization within the plasma membrane.
    Orcel H; Albizu L; Perkovska S; Durroux T; Mendre C; Ansanay H; Mouillac B; Rabié A
    Mol Pharmacol; 2009 Mar; 75(3):637-47. PubMed ID: 19047484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. O-Glycosylation of the V2 vasopressin receptor.
    Sadeghi H; Birnbaumer M
    Glycobiology; 1999 Jul; 9(7):731-7. PubMed ID: 10362843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the glycosylation sites utilized on the V1a vasopressin receptor and assessment of their role in receptor signalling and expression.
    Hawtin SR; Davies AR; Matthews G; Wheatley M
    Biochem J; 2001 Jul; 357(Pt 1):73-81. PubMed ID: 11415438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Processing and ligand-induced modifications of the V2 vasopressin receptor.
    Sadeghi HM; Innamorati G; Esqueda E; Birnbaumer M
    Adv Exp Med Biol; 1998; 449():339-46. PubMed ID: 10026823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Appropriate polarization following pharmacological rescue of V2 vasopressin receptors encoded by X-linked nephrogenic diabetes insipidus alleles involves a conformation of the receptor that also attains mature glycosylation.
    Tan CM; Nickols HH; Limbird LE
    J Biol Chem; 2003 Sep; 278(37):35678-86. PubMed ID: 12824183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors-molecular dynamics study of the activated receptor-vasopressin-G(alpha) systems.
    Slusarz MJ; Giełdoń A; Slusarz R; Ciarkowski J
    J Pept Sci; 2006 Mar; 12(3):180-9. PubMed ID: 16114100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of low-glycosylated forms of soluble human urokinase receptor expressed in Drosophila Schneider 2 cells after deletion of glycosylation-sites.
    Gårdsvoll H; Werner F; Søndergaard L; Danø K; Ploug M
    Protein Expr Purif; 2004 Apr; 34(2):284-95. PubMed ID: 15003263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elucidation of signaling properties of vasopressin receptor-related receptor 1 by using the chimeric receptor approach.
    Gupte J; Cutler G; Chen JL; Tian H
    Proc Natl Acad Sci U S A; 2004 Feb; 101(6):1508-13. PubMed ID: 14757815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: comparison with Asn216 in VPAC2 receptor.
    Nachtergael I; Gaspard N; Langlet C; Robberecht P; Langer I
    Cell Signal; 2006 Dec; 18(12):2121-30. PubMed ID: 16650965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cloning and characterization of the human V3 pituitary vasopressin receptor.
    de Keyzer Y; Auzan C; Lenne F; Beldjord C; Thibonnier M; Bertagna X; Clauser E
    FEBS Lett; 1994 Dec; 356(2-3):215-20. PubMed ID: 7805841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression cloning of an AVP-activated, calcium-mobilizing receptor from rabbit kidney medulla.
    Burnatowska-Hledin MA; Spielman WS; Smith WL; Shi P; Meyer JM; Dewitt DL
    Am J Physiol; 1995 Jun; 268(6 Pt 2):F1198-210. PubMed ID: 7611460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.